William Blair Issues Positive Forecast for CRL Earnings
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – William Blair raised their Q2 2025 earnings estimates for shares of Charles River Laboratories International in a research report issued to clients and investors on Wednesday, May 7th. William Blair analyst M. Smock now expects that the medical research company will post earnings of $2.49 […]
